Citigroup Inc Outset Medical, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Outset Medical, Inc. stock. As of the latest transaction made, Citigroup Inc holds 225 shares of OM stock, worth $254. This represents 0.0% of its overall portfolio holdings.

Number of Shares

225

Previous 21,307 98.94%

Holding current value

$254

Previous $82,000 100.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.45 - $4.82 $9,486 - $101,615	-21,082 Reduced 98.94%	225 $0
Q2 2024 Aug 12, 2024	BUY	$1.94 - $4.61 $25,132 - $59,722	12,955 Added 155.11%	21,307 $82,000
Q1 2024 May 10, 2024	SELL	$1.99 - $5.64 $46,086 - $130,616	-23,159 Reduced 73.49%	8,352 $18,000
Q4 2023 Feb 09, 2024	BUY	$3.07 - $10.25 $90,162 - $301,032	29,369 Added 1371.1%	31,511 $170,000
Q3 2023 Nov 09, 2023	SELL	$10.52 - $20.68 $165,237 - $324,820	-15,707 Reduced 88.0%	2,142 $23,000
Q2 2023 Aug 10, 2023	BUY	$17.18 - $23.76 $254,796 - $352,384	14,831 Added 491.42%	17,849 $390,000
Q1 2023 May 11, 2023	BUY	$18.25 - $30.26 $1,843 - $3,056	101 Added 3.46%	3,018 $55,000
Q4 2022 Feb 09, 2023	SELL	$12.36 - $26.41 $10,481 - $22,395	-848 Reduced 22.52%	2,917 $75,000
Q3 2022 Nov 10, 2022	SELL	$14.67 - $21.7 $36,322 - $53,729	-2,476 Reduced 39.67%	3,765 $60,000
Q2 2022 Aug 10, 2022	BUY	$13.46 - $48.16 $14,779 - $52,879	1,098 Added 21.35%	6,241 $93,000
Q1 2022 May 12, 2022	SELL	$34.22 - $47.24 $690,046 - $952,594	-20,165 Reduced 79.68%	5,143 $234,000
Q4 2021 Feb 10, 2022	SELL	$43.29 - $58.77 $9,220 - $12,518	-213 Reduced 0.83%	25,308 $1.17 Million
Q3 2021 Nov 10, 2021	BUY	$36.86 - $54.98 $940,704 - $1.4 Million	25,521 New	25,521 $1.26 Million

Others Institutions Holding OM

# of Institutions

Shares Held

19.9M

Call Options Held

66.8K

Put Options Held

60.3K

View Full List

About Outset Medical, Inc.

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $54.2M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

More about OM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account